Three entities, one unified vision: extending human life and expanding beyond our planet are complementary and inevitable steps in the evolution of our species.
The work of REGENEVIA, GenAtlantica Life Sciences, and REGENEVIA SPACE is guided by a shared scientific and philosophical framework.
Although each organization operates in a distinct domain — epigenetic rejuvenation, longevity research, and fundamental physics — they are united by a common understanding: human evolution is constrained not only by biology, but by information, environment, and scale.
The Group’s vision embraces both dimensions, recognizing that progress at the cellular scale and progress at the civilizational scale must evolve in parallel.
Epigenetic Rejuvenation
Each entity within Lynch Group operates independently, with distinct governance, funding structures, and research objectives.
Restoring biological order at the cellular level through epigenetic modulation, with the goal of improving longevity, resilience, and quality of life. 5 USPTO patents protect our core innovations.
Longevity Research
Exploring the broader scientific foundations of aging, longevity, and biological stability, bridging research and translational insight. Founded in London in 2016.
Fundamental Physics & Space
Addressing the physical and technological limits of human expansion in space through research in fundamental physics, cosmology, and the patented PAMK-Drive propulsion system.
At its core, the Group’s vision recognizes that the preservation and extension of human life cannot be separated from the long-term future of humanity itself.
Extending the duration and quality of human life, and expanding beyond the limits of our planet, are not separate ambitions — they are complementary and inevitable steps in the evolution and long-term survival of our species.
Each initiative contributes to this broader objective through rigorous science, responsible innovation, and long-term thinking, without shortcuts or speculative promises.
Discover the research, innovations, and vision behind each pillar of the Lynch Group.
REGENEVIA BIO
Epigenetic Science & Cellular Reprogramming Research
Privacy Policy · Terms of Use · Disclaimer | Cookie Policy
© 2025 Regenevia Bio. All rights reserved. Part of the Lynch Group.
REGENEVIA BIO utilizza WordPress
Peer-reviewed preprints and patent filings — Open Access on Zenodo (CERN)